Cutting-edge progress also continues in retina, cornea, dry eye, gene-based science
A rundown of the most interesting research in a variety of subspecialties presented at this year’s ARVO meeting.
Section Editor Ryan Bouchard interviews John Berdahl, MD.
Phase 3 Allergy Program Establishes Clinical Indication Expansion Strategy of DEXTENZA™